Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
214.20    1.20 (0.56%)
Bid:
213.80
Ask:
214.20
Spread: 0.40 (0.187%)
Market Cap: £4.19b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Result of AGM

7 May 2020 16:15

RNS Number : 3272M
ConvaTec Group PLC
07 May 2020
Β 

ConvaTec Group Plc

Β 

Results of Annual General Meeting

Β 

Reading, United Kingdom 7 May 2020 - Poll Result

Β 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today ("Meeting"), The results of the poll held in relation to the resolutions proposed at the Meeting are set out below.

Β 

Β 

For

(see note 2)

Against

(see note 2)

Total Votes

% of ISC Voted

Number of Votes Withheld

(see note 3

Resolution

No of shares

%

No of Shares

%

1

Receive Annual Report and Accounts

1,689,253,478

99.99

162,424

0.01

1,689,415,902

85.17

1,375,861

2

Approve the Directors' Remuneration Report

1,459,271,427

86.35

230,658,135

13.65

1,689,929,562

85.20

908,684

3

Approve the Directors' Remuneration Policy

1,479,320,219

87.54

210,611,343

12.46

1,689,931,562

85.20

906,684

4

Declare Final Dividend

1,670,311,992

98.79

20,526,249

1.21

1,690,838,241

85.24

6

5

Elect John McAdam as a director

1,686,038,868

99.72

4,725,844

0.28

1,690,764,712

85.24

73,534

6

Elect Karim Bitar as a director

1,687,089,831

99.78

3,746,388

0.22

1,690,836,219

85.24

2,028

7

Elect Brian May as a director

1,689,080,374

99.90

1,749,450

0.10

1,690,829,824

85.24

8,423

8

Re-elect Frank Schulkes as a director

1,684,095,328

99.60

6,734,291

0.40

1,690,829,619

85.24

8,628

9

Re-elect Margaret Ewing as a director

1,662,219,417

98.31

28,611,702

1.69

1,690,831,119

85.24

7,128

10

Re-elect Rick Anderson as a director

1,686,272,799

99.73

4,561,920

0.27

1,690,834,719

85.24

3,528

11

Re-elect Regina Benjamin as a director

1,678,521,751

99.30

11,891,727

0.70

1,690,413,478

85.22

424,768

12

Re-elect Ros Rivaz as a director

1,630,402,633

96.47

59,672,747

3.53

1,690,075,380

85.21

762,866

13

Re-elect Sten Scheibye as a director

1,687,084,151

99.78

3,745,468

0.22

1,690,829,619

85.24

8,628

14

Re-appoint Deloitte LLP as auditor

1,690,827,240

100.00

9,746

0.00

1,690,836,986

85.24

1,261

15

Authorise the directors to determine the remuneration of the Company's auditor

1,690,692,456

100.00

5,000

0.00

1,690,697,456

85.24

140,791

16

Authorise political donations and political expenditure

1,679,778,558

99.35

11,050,957

0.65

1,690,829,515

85.24

8,732

17

Authorise allotment of shares

1,576,731,448

93.28

113,598,212

6.72

1,690,329,660

85.22

508,587

18

Disapply pre-emption rights*

1,665,615,258

98.53

24,844,432

1.47

1,690,459,690

85.23

378,557

19

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,664,010,440

98.44

26,449,249

1.56

1,690,459,689

85.23

378,557

20

Authorise purchase of own shares*

1,669,151,425

98.76

20,937,729

1.24

1,690,089,154

85.21

749,092

21

Call general meetings on 14 days' notice*

1,663,148,185

98.36

27,687,156

1.64

1,690,835,341

85.24

2,906

Β 

*Special Resolution

Β 

NOTES:

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at close of business on 6 May 2020 was 1,983,513,851 shares; 85.24% of voting capital was instructed.

5. Computershare acted as scrutineer of the poll on all resolutions.

Β 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Β 

Β 

About ConvaTec

Β 

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

Β 

Β 

Β 

Enquiries

Β 

Β 

Analysts and Investors

Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625

ir@convatec.com

Β 

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207 466 5000

Β 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

Β 

Β 

Β 

Β 

Β 

Β 

# # #

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RAGUBAVRRRUVRAR
Date   Source Headline
3rd Jul 20263:00 pmRNSHolding(s) in Company
30th Jun 20263:00 pmRNSHolding(s) in Company
25th Jun 202611:00 amRNSHolding(s) in Company
28th May 202611:00 amRNSHolding(s) in Company
27th May 202611:00 amRNSDirector/PDMR Shareholding
26th May 202611:00 amRNSHolding(s) in Company
21st May 20263:30 pmRNSResults of AGM
21st May 20267:00 amRNSAGM trading update for four months ended 30 April
13th Apr 202612:00 pmRNSProfessor Constantin Coussios steps down
9th Apr 20267:00 amRNSCapital Markets Day
17th Mar 20261:00 pmRNSNotice of AGM
17th Mar 202611:00 amRNSDirector/PDMR Shareholding
12th Mar 20262:30 pmRNSDirector/PDMR Shareholding
10th Mar 20261:00 pmRNSPublication of Annual Report
24th Feb 20267:00 amRNSConvatec FY25 Results
6th Feb 202611:00 amRNSHolding(s) in Company
2nd Jan 202611:00 amRNSTotal Voting Rights
19th Dec 202512:00 pmRNSHolding(s) in Company
19th Dec 202512:00 pmRNSHolding(s) in Company
17th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20253:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 202512:00 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 202511:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20255:30 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20251:30 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20256:00 pmRNSConvaTec Group
18th Nov 20257:00 amRNSPRICED SECONDARY OFFERING IN CONVATEC GROUP PLC
17th Nov 20254:57 pmRNSPROPOSED SECONDARY OFFERING IN CONVATEC GROUP PLC
14th Nov 20253:00 pmRNSHolding(s) in Company
13th Nov 20257:05 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTrading update for 10 months ended 31 October 2025
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.